Jeena Sikho Lifecare launches Ayurvedic and nutraceutical product lines
- Launched eight new Ayurvedic and nutraceutical products on October 5, 2026
- Introduced Acharya Ji Vati tablets and Jod Xpert joint care line
- Expanded nutraceutical range with gender-specific plant protein variants
- All new products are targeted exclusively at the domestic market
*this image is generated using AI for illustrative purposes only.
Jeena Sikho Lifecare Limited launched eight new Ayurvedic healthcare and nutraceutical products on October 5, 2026, expanding its wellness portfolio. The launch includes Acharya Ji Vati variants and gender-specific plant protein supplements targeted at the domestic market.
The company filed an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, to the National Stock Exchange of India Limited and BSE Limited. The disclosure confirms the addition of these items to its existing range of Ayurvedic clinics and hospital-linked products.
New Product Portfolio Details
The newly launched products are categorized into two primary segments: Ayurvedic tablets and oils, and nutraceutical plant proteins. All products are designated for the domestic market only, with no international launch plans disclosed in the filing.
| Product Name | Category | Form/Variant |
|---|---|---|
| Acharya Ji Arogyam Vati | Ayurvedic Healthcare | Tablets (60 Tab) |
| Acharya Ji Niogyam Vati | Ayurvedic Healthcare | Tablets (60 Tab) |
| Jod Xpert Oil | Ayurvedic Healthcare | Oil (100 ML) |
| Jod Xpert Roll-On | Ayurvedic Healthcare | Roll-On (50 ML) |
| Jod Xpert Tablet | Ayurvedic Healthcare | Tablets (60 Tab) |
| Jeena Sikho Plant Protein General | Nutraceutical | Chocolate/Mango/Coffee (500 Gm) |
| Jeena Sikho Plant Protein Men | Nutraceutical | Chocolate/Mango/Coffee (500 Gm) |
| Jeena Sikho Plant Protein Women | Nutraceutical | Chocolate/Mango/Coffee (500 Gm) |
Strategic Portfolio Expansion
The launch strengthens the company's presence in the Ayurvedic healthcare and wellness sector. The introduction of gender-specific plant proteins indicates a strategy to capture niche consumer segments within the broader nutraceutical market. The Jod Xpert line addresses joint health through multiple delivery formats, including oil, roll-on, and tablets.
What the Numbers Show
The filing reveals a concentrated product rollout focused exclusively on the domestic market. Out of the eight new SKUs, three are variations of a single joint-health brand (Jod Xpert), while another three are flavor variants of the same plant protein base. This suggests a strategy of leveraging existing brand equity and manufacturing capabilities to maximize shelf presence with minimal diversification risk, rather than entering entirely new therapeutic categories.
Historical Stock Returns for Jeena Sikho Lifecare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -6.43% | -11.98% | -10.64% | -23.58% | -44.60% | +2,235.93% |
How will Jeena Sikho Lifecare's domestic-only strategy impact its long-term revenue growth compared to competitors pursuing international expansion?
What specific distribution channels and marketing partnerships is the company leveraging to penetrate the competitive gender-specific nutraceutical segment?
How might the regulatory environment for Ayurvedic products in India evolve, and what compliance costs could affect the profitability of the new Jod Xpert line?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
